737789-87-6 Relugolix

Pwopriyete

Aparans blan nan koupe-blan cristalline solid
Pwen k ap fonn: 228 degre (decomp)
Dansite 1.442 ± 0. 06 g/cm3
Depo tanperati. Magazen nan -20 degre
solubility dmso: 2 0. 0 (max conc. mg/ml); 32.1 (max conc. mm)
Etanòl: 1. 0 (max conc. Mg/ml); 1.6 (max conc. Mm)
 

Aplikasyon:

Relugolix se yon antagonist GnRH, ke yo rele tou yon antagonist reseptè òmòn gonadotropin-divilge. Kontrèman ak pifò lòt modulateur GnRH, men menm jan ak Elagolix (non komès Orilissa), Relugolix se yon konpoze molekil ki pa peptides ki ka pran oralman. Li ka siprime nivo yo nan òmòn sèks gason ak fi nan ranje a menopoz oswa castration.

 

Sinonim:

Relugolix

737789-87-6

Tak -385

Orgovyx

Tak 385

1- (4- (1- (2, 6- difluorobenzyl) -5- ((dimethylamino) methyl) {{6} -3- yl) -2, 4- dioxo -1, 2,3, 4- 18}} Methoxyurea

MyFembree Component Relugolix

1- [4- [1- [(2, 6- difluorophenyl) methyl] -5- [(dimethylamino) methyl] -3- ({{7 }} methox ypyridazin -3- yl) -2, 4- dioxothieno [2, 3- d] pyrimidin -6- yl] fenil] -3- methoxyurea

N-(4- (1- ((2, 6- difluorophenyl) methyl) -5- ((dimethylamino) methyl) -1, 2,3, {{{{ 9}} Tetrahydro -3- ( 6- methoxy -3- Pyridazinyl) -2, 4- dioxothieno (2, 3- d) Pyrimidin -6- yl) phenyl) -n'-Methoxhoxin {}

Ure, N-(4- (1- ((2, 6- difluorophenyl) methyl) -5- ((dimethylamino) methyl) -1, 2,3, {{{{ 9}} Tetrahydro -3- (6- methoxy -3- piridazinyl) -2, 4- dioxothieno (2, 3- d) Pyrimidin -6- yl) phenyl) -n'- metoksi-

Relugolix

relugolixum

Tak385

1- (4- (1- ((2, 6- difluorophenyl) methyl) -5- ((dimethylamino) methyl) -3- ({{7 }} Methoxypyridazin {{8} } Yl) -2, 4- dioxo -1, 2,3, 4- ) -3- methoxyurea

1- (4- {1- [(2, 6- difluorophenyl) methyl] -5- [(dimethylamino) methyl] -3- ({{7 }} methoxypyridazin {{8} } yl) -2, 4- dioxo -1, 2,3, 4- ) -3- methoxyurea

Orgovyx

 

Baj popilè: 737789-87-6 Relugolix, Lachin 737789-87-6 Relugolix Konpayi fabrikasyon, Swèd